Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-20-000804
Filing Date
2020-03-17
Accepted
2020-03-17 21:23:10
Documents
1
Period of Report
2020-03-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form307422010_03172020.html 3  
1 OWNERSHIP DOCUMENT form307422010_03172020.xml 3 12129
  Complete submission text file 0000921895-20-000804.txt   14930
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF I GP LLC (Reporting) CIK: 0001803805 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 20722988

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF II GP LLC (Reporting) CIK: 0001803806 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 20722989

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF GP HOLDINGS LLC (Reporting) CIK: 0001803809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-14710 | Film No.: 20722987